Romainville Cedex
France
14
2014-04-24
4
2014-12-09
These are the the leading inventors for applications assigned to Cellectis:
Cellectis based in Romainville Cedex, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
METHOD FOR ENHANCING THE CLEAVAGE ACTIVITY OF I-CREI DERIVED MEGANUCLEASES
#2 | 2013-08-29USE OF ENDONUCLEASES FOR INSERTING TRANSGENES INTO SAFE HARBOR LOCI
#3 | 2013-07-25 ✅ Patent 8,906,607 granted on 2014-12-09Method for modulating double-strand break-induced homologous recombination
#4 | 2011-09-15 ✅ Patent 9,273,296 granted on 2016-03-01Meganuclease variants cleaving a DNA target sequence from a glutamine synthetase gene and uses thereof
#5 | 2011-08-25NOVEL METHOD TO GENERATE MEGANUCLEASES WITH ALTERED CHARACTERISTICS
#6 | 2011-07-14CHIMERIC MEGANUCLEASE ENZYMES AND USES THEREOF
#7 | 2011-04-21MEGANUCLEASE VARIANTS CLEAVING A DNA TARGET SEQUENCE FROM THE HUMAN INTERLEUKIN-2 RECEPTOR GAMMA CHAIN GENE AND USES THEREOF
#8 | 2011-02-17I-MSOI HOMING ENDONUCLEASE VARIANTS HAVING NOVEL SUBSTRATE SPECIFICITY AND USE THEREOF
#9 | 2010-12-23 ✅ Patent 8,426,177 granted on 2013-04-23Meganuclease variants cleaving a DNA target sequence from the mouse ROSA26 locus and uses thereof
#10 | 2010-09-09MEGANUCLEASE VARIANTS CLEAVING A DNA TARGET SEQUENCE FROM THE HUMAN HEMOGLOBIN BETA GENE AND USES THEREOF
#11 | 2010-08-12METHOD FOR ENHANCING THE CLEAVAGE ACTIVITY OF I-CREI DERIVED MEGANUCLEASES
#12 | 2010-04-08LAGLIDADG HOMING ENDONUCLEASE VARIANTS HAVING NOVEL SUBSTRATE SPECIFICITY AND USE THEREOF
#13 | 2010-01-28 ✅ Patent 7,935,722 granted on 2011-05-03Tetrahydrocarbazole derivatives useful as androgen receptor modulators
#14 | 2009-10-29MEGANUCLEASE VARIANTS CLEAVING A DNA TARGET SEQUENCE FROM A RAG GENE AND USES THEREOF
31824 ⎘